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Abstract 
The prevalence of type 2 diabetes is increasing at an alarming rate. Various complications are 
associated with type 2 diabetes, with diabetic nephropathy being the leading cause of renal 
failure among diabetics. Often, when patients are diagnosed with diabetic nephropathy, their 
renal functions have already been significantly damaged, speeding up the progression 
towards end stage renal disease. Therefore, a risk prediction tool may be beneficial for the 
implementation of early treatment and prevention. In the present study, we propose to 
develop a prediction model integrating clustering and classification approaches for the 
identification of diabetic nephropathy among type 2 diabetes patients. Clinical and 
genotyping data are obtained from 345 type 2 diabetic patients(160 with non-diabetic 
nephropathy and 185 with diabetic nephropathy). The performance of using clinical features 
alone for cluster-based classification is compared with that of utilizing a combination of 
clinical and genetic attributes. We find that the inclusion of genetic features yield better 
prediction results. Further refinement of the proposed approach has the potential to facilitate 
the accurate identification of diabetic nephropathy and the development of better treatment in 
a clinical setting.   
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1. Introduction 
Diabetes is a metabolic disorder contributed by multiple factors, including diet, lifestyle, and 
genes. Despite the advancement in health care, the prevalence of diabetes is still on the rise, 
with more than 150 million people worldwide being affected with this debilitating disease [1]. 
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Diabetes can result invarious complications, damaging the heart, blood vessels, eyes, kidneys, 
and nerves. Currently, more than 1.5 million people are affected with T2D in Taiwan.  
 
Previously, we conducted a candidate gene analysis on 345 T2D patients, analyzing the 
association of 20 candidate genes with T2D, as well as the related complications such as 
obesity and diabetic nephropathy (DN).Through the generalized multi-dimensional reduction 
approach [2], we identified various gene-gene interactions that may represent genetic 
susceptibilities to T2D, obesity, and DN[3]. Our findings suggest that T2D and DN may be 
attributable to multiple factors that include the interactions between genes and the 
environment.  
 
As the major contributor of end-stage renal disease (ESRD), DN is one of the most fatal 
complications of diabetes [4]. Compared to non-diabetics, the likelihood of dying from renal 
disease is 17 times greater for diabetics [5]. DN affects about 30% of the people with type 1 
diabetes, and 25-40% of the people with T2D [6, 7]. Unfortunately, the exact mechanisms 
underlying the progression from DN to ESRD is not yet fully understood.  
 
Generally, DN symptoms are not obvious. In type 1 diabetic patients, DN develops over an 
initial 10 to 15 years of diabetes; whereas in type 2 diabetic patients, the onset is less clearly 
defined [8]. When clinical indices for renal functions (e.g. urinary protein level) become 
abnormal, the kidneys have already been significantly damaged and prevention against ESRD 
may already be too late at this stage [9]. Thus, it would be beneficial to develop a prediction 
model utilizing more indirect clinical measures, such as gender, history of diabetes, body 
mass index (BMI), etc. Moreover, since existing studies suggest that genes play a role in 
diabetes and DN risk [3, 10], integrating genetic information in the prediction of DN 
susceptibility may lead to more accurate identification.  
 
In the present study, we propose to employ a cluster-based classification approach to identify 
DN among T2D patients. Compared to using clinical features alone for the classification, we 
find that the integration of clinical and genetic features yields a higher performance in 
distinguishing DN from non-DN diabetic patients.  
 
2. Materials and Methods 
2.1  T2D data 
The T2D data consists of 345 Taiwanese patients who were recruited form the Tri-Service 
General Hospital in Taipei in 2002[3, 11].The case group comprises 185 T2D patients with 
DN, and the control group comprised 160 T2D without DN. Table 1 provides an overview of 
the demographic and clinical data of these participants. 
 
2.2  Clinical and Genetic Feature selection 
In our previous studies [3, 11], statistical analyses have already identified clinical and genetic 
attributes that show significant differences between the control and case groups. These 
statistically significant features are selected as the clinical and genetic features for the present 
study and are shown in Tables 1 and 2, respectively.  
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Table 1. Demographic and clinical characteristics of the study subjects 
 
 
Table 2.Genotype distributions of the significant candidate genes in T2D patients with and without 
DN. 
 
2.3 System Flow 
The performances of classifying DN based on clinical and genetic features separately are 
compared with that of cluster-based classification integrating clinical and genetic features. 
There are too many factors that can lead to diabetes and its associated complications.We 
believe that the cluster-based classification approach [12] approach should increase the 
accuracy of DN identification. Experiments are conducted in WEKA 3.6.5 tool[13]. Weka 
(Waikato Environment for Knowledge Analysis) is a JAVA based platform for data mining 
and data analysis. We used clustering package inside. We used the K means clustering 
package for clustering.Clustering is the process of grouping similar elements andthe K means 
algorithm is a method of vector quantization originally derived for signal processing and later 
evolved into a popular clustering approach in data mining[14].Then, we used the C4.5 
decision tree in WEKA. This is a well-known classification technique in decision tree 
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induction [15]. The parameter setting are c=0.5 and M=2 for the confidence factor and 
minimum number of objects, respectively. 
 
Fig. 1 System flow of the proposed cluster-based classification approach for the identification 
of DN among T2D patients. 
 
Finally, we use a 10-fold cross validation of the data to evaluate the performance of the 
proposed approach in accuracy, sensitivity, specificity.For the measurement of accuracy, 
sensitivity and specificity, the following mathematical model is used, where TP represents the 
correctly identifiedtrue positive; FP indicates the incorrectly identified false positive; TN is 
the correctly rejected true negative; FN stands for the incorrectly rejected falsenegative.Table 
3 describes each performance measures in the context of DN classification.  
 𝑐𝑐𝑢𝑟𝑎𝑐𝑦  
 𝑃 +  𝑁
T + F + T + F 
 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦  
 𝑃
T + F 
 
𝑆𝑝𝑒𝑐𝑖 𝑖𝑐𝑖𝑡𝑦  
 𝑁
T + F 
 
 
Table 3.True Positive, True Negative, False Positive and False Negative confusion matrix for 
DN classification. 
Predict Classified as DN Classified as not DN 
T2D with DN TP FN 
T2D without DN FP TN 
 
3. Results and Discussions 
The performances of using clinical features or genetic features alone for DN classification are 
shown in Tables 4 and 5, respectively. The classification accuracy measures seem to be low. 
Perhaps these approaches ignore the possible interactions among genes and clinical traits that 
underlie the disease mechanisms of DN. Thus, we decide to employ a cluster-based 
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classification approach, employing a combination of clinical and genetic attributes. 
Performance of the proposed approach is shown in Table 6. The proposed approach 
outperforms the classification methods based on clinical or genetic features separately.  
 
Table 4.Accuracy measures for DN classification based on clinical features 
Parameter Accuracy 
LDL 53.62% 
HDL 56.36% 
Serum triglycerol 62.61% 
 
 
Table 5.Accuracy measures for DN classification based on genetic features 
Parameter Accuracy 
PPAR 51.62% 
UCP1 53.62% 
UCP3 53.47% 
 
Our present finding supports the previous study that the mechanisms underlying DN may 
involve the interactions between genes and the environment. Each genetic or clinical 
attributes may contribute marginal effects to DN. Therefore, when predicting DN among T2D 
patients, it may be important to consider both genetic and clinical factors. Using a 
cluster-based classification approach, we also provide support for the notion that complex 
diseases like T2D and its associated DN complication are genetically heterogeneous. The 
same genetic features that may help predict DN susceptibility for one individual may not 
apply for everyone. However, grouping individuals based on clinical similarities and classify 
individuals with DN may represent a logical solution.  
 
To our knowledge, as the disease mechanisms of DN are complex and the symptoms are not 
obvious, there are no accurate diagnostic methods for DN. We believe the proposed approach, 
with further refinement in parameter settings and testing in a bigger sample size, may have 
the potential to facilitate the early identification of individuals with DN susceptibility and 
therefore, early prevention or treatment for DN. 
 
Table6.Cluster-based classification integrating clinical and genetic attributes 
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